Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Esophageal Neoplasms and XRCC3[original query] |
|---|
| DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy. Annals of surgical oncology 2011 Sep 18 (9): 2688-98. Ott Katja, Rachakonda P Sivaramakrishna, Panzram Benjamin, Keller Gisela, Lordick Florian, Becker Karen, Langer Rupert, Buechler Markus, Hemminki Kari, Kumar Raj |
| Variants in multiple genes are associated with esophageal cancer risk in a Chinese Han population: A case-control study. The journal of gene medicine 2020 Aug e3266. Xiong Zichao, Wu Jiamin, Sun Yao, Bai Mei, Niu Fanglin, Jin Tian |
| Association of XRCC1, XRCC2 and XRCC3 Gene Polymorphism with Esophageal Cancer Risk. Clinical and experimental gastroenterology 2020 13 73-86. Kaur Jagjeet, Sambyal Vasudha, Guleria Kamlesh, Singh Neeti Rajan, Uppal Manjit Singh, Manjari Mridu, Sudan Mee |
| Relevance of pharmacogenetic polymorphisms with response to docetaxel, cisplatin, and 5-fluorouracil chemotherapy in esophageal cancer. Investigational new drugs 2021 11 40 (2): 420-429. Nomura Hisanaga, Tsuji Daiki, Ueno Shohei, Kojima Takashi, Fujii Satoshi, Yano Tomonori, Daiko Hiroyuki, Demachi Ken, Itoh Kunihiko, Kawasaki Toshikat |
- Page last reviewed:Feb 1, 2024
- Content source: